SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-014868
Filing Date
2022-04-18
Accepted
2022-04-18 16:30:40
Documents
14
Period of Report
2022-04-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT brhc10036367_8k.htm   iXBRL 8-K 45818
2 REVISED PRESENTATION OF FINANCIAL RESULTS brhc10036367_ex99-1.htm EX-99.1 686092
  Complete submission text file 0001140361-22-014868.txt   946192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20220418.xsd EX-101.SCH 4754
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20220418_def.xml EX-101.DEF 18396
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20220418_lab.xml EX-101.LAB 28485
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20220418_pre.xml EX-101.PRE 20689
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10036367_8k_htm.xml XML 8437
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 22832457
SIC: 2834 Pharmaceutical Preparations